Selenium in the treatment of mild-to-moderate Graves' orbitopathy: a 5-year prospective controlled cohort study.
Chuyuan WangJing QiaoShanshan LiuSichen PiaoYun ZhouYuedong HuChao WanYizhou SunHong NingLei ChenHe ZhangRuolin HuHaoyu WangWeiwei WangLei ZhaoJinyuan MaoMin LiWeiping TengZhongyan ShanYushu LiPublished in: Endocrine (2024)
Six months of selenium supplementation may effectively change the early course of mild-to-moderate GO, but this regimen makes no difference in long-term outcomes.
Keyphrases